Tratamiento del dolor y otras molestias en los pacientes quemados  
Tratamientos no farmacológicos en los pacientes quemados
155. Filkin SA, Cosgrav P, Marvin JA, et al. Self-administered anesthesia: a method of pain control. J Burn Care Rehabil 1981; 2:33-34.
156. Marvin JA, Engrav LH, Heimbach DM. Self-administered nitrous oxide analgesia for debridement: a five year experience. Presented
at the 16th Annual Meeting of the American Burn Association, San Francisco, California: April 11-14, 1984. 157. Layzer RH.
Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 1978; 2:1227-1230. 158. Layzer RB, Fishman RA, Schafer JA.
Neuropathy following abuse of nitrous oxide. Neurology 1978; 28:504-506. 159. Paulson GW. Recreational misuse of nitrous oxide. J
Am Dent Assoc 1979; 98:410-411. 160. Hayden PJ, Hartemink RJ, Nicholson GA. Myeloneuropathy due to nitrous oxide. Burns 1983;
9:267-270. 161. Baskett PJE, Hyland J, Deane M, et al. Analgesia for patient dress ing in children. Br J Anaesth 1969; 41:684-688. 162.
Baskett PJE. Analgesia for the dressing of burns in children: a method using neuroleptanalgesia and Entonox. Postgrad Med J 1972;
48:138-142. 163. Vieira E, Cleaton-Jones P, Austin JC. Effects of low concentrations of nitrous oxide on rat fetuses. Anesth Analg 1980;
59:175-177. 164. Vieira E. The effect of the chronic administration of nitrous oxide 0.54 to gravid rats. Br J Anaesth 1979; 51:283-287.
165. Heinrich M, Wetzstein V, Muensterer OJ, et al. Conscious sedation: off-label use of rectal s()-ketamine and midazolam for wound
dressing changes in paediatric heat injuries. Eur J Pediatr Surg 2004; 14:235-239. 166. Slogoff S, Allen GW, Wessels JV, et al. Clinical
experience with subanesthetic ketamine. Anesth Analg Curr Res 1974; 53: 354-358. 167. Martinez S, Achauer B, Dobkin de Rios M.
Ketamine use in a burn center: hallucinogen or debridement facilitator. J Psychoactive Drugs 1985; 17:45-49. 168. Handrop M, Spinella
J. Ketamine: featured protocol. J Burn Care Rehabil 1987; 8:148-149. 169. Parker J. Ketamine: review of featured protocol. J Burn Care
Rehabil 1987; 8:149. 170. Martyn JAJ. Ketamine pharmacology and therapeutics. J Burn Care Rehabil 1987; 8:146-148. 171. Dimick P,
Helvig E, Heimbach D, et al. Anesthesia assisted proce dures in a burn intensive care unit procedure room: benefits and complications. J
Burn Care Rehabil 1993; 14:446-449. 172. Sebel PS, Lowdon JD. Propofol: a new intravenous anesthetic. Anesthesiology 1989; 71:260-
277. 173. Coimbra C, Choinière M, Hemmerling RM. Patient-controlled sedation using propofol for dressing changes in burn patients: a
dose-finding study. Anesth Analg 2003; 97:839-842. 174. Cravero JP, Manzi DJ, Rice LJ. The management of procedure-related pain the
child. In: Ashburn MA, Rice LJ, eds. The management of pain. New York: Churchill Livingston; 1998. 175. Wolf AR, Potter F. Propofol
infusion in children: when does an anesthetic tool become an intensive care liability? Pediatr Anesth 2004; 14:435-438. 176. Tobias JD.
Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 2005; 34:636-645. 177. Ronan KP, Gallagher TJ, George B, et al.
Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med 1995; 23:286-293. 178. Hughes MA,
Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetics models for intravenous anes thetic drugs.
Anesthesiology 1992; 76:334-341. 179. Mathru M, Esch O, Lang J, et al. Magnetic resonance imaging of the upper airway. Effect of
propofol anesthesia and nasal continu ous positive airway pressure in humans. Anesthesiology 1996; 84:253-255. 180. Veber B,
Gachot B, Bedos JP, et al. Severe sepsis after intravenous injection of contaminated propofol. Anesthesiology 1994; 80:712-713.

tratamiento vasitos piernas bucaramanga